This study is accepting new patients by invitation only
An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID
Summary
- Location
- at UCLA
- Dates
- study startedcompletion around
- Principal Investigator
- by Donald B. Kohn, M.D. (ucla)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Donald B. Kohn, M.D. (ucla)
Professor, MIMG, Medicine. Authored (or co-authored) 254 research publications
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, Los Angeles
- ID
- NCT04049084
- Study Type
- Observational
- Participants
- Expecting 70 study participants
- Last Updated